News headlines about Natera (NASDAQ:NTRA) have trended positive this week, according to AlphaOne Sentiment Analysis. The research group, a unit of Accern, rates the sentiment of news coverage by reviewing more than twenty million news and blog sources. AlphaOne ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Natera earned a media sentiment score of 0.26 on AlphaOne’s scale. AlphaOne also assigned media coverage about the medical research company an impact score of 0 out of 100, indicating that recent news coverage is extremely unlikely to have an impact on the stock’s share price in the near future.
NTRA has been the subject of several research reports. Canaccord Genuity restated a “buy” rating on shares of Natera in a research note on Monday, January 30th. Zacks Investment Research upgraded Natera from a “sell” rating to a “buy” rating and set a $11.00 price target for the company in a research note on Wednesday, May 10th. Finally, Cowen and Company cut their price target on Natera from $17.00 to $14.00 and set an “outperform” rating for the company in a research note on Tuesday, March 14th. One investment analyst has rated the stock with a sell rating, one has given a hold rating and four have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus price target of $16.20.
Shares of Natera (NASDAQ:NTRA) traded down 1.84% during trading on Friday, hitting $10.16. The stock had a trading volume of 59,872 shares. The stock has a 50 day moving average of $9.00 and a 200 day moving average of $9.93. Natera has a 52-week low of $7.35 and a 52-week high of $13.80. The firm’s market cap is $537.28 million.
Natera (NASDAQ:NTRA) last released its quarterly earnings data on Tuesday, May 9th. The medical research company reported ($0.70) EPS for the quarter, missing the consensus estimate of ($0.61) by $0.09. The business had revenue of $46.90 million during the quarter, compared to analysts’ expectations of $42.82 million. Natera had a negative net margin of 36.64% and a negative return on equity of 48.24%. The firm’s revenue was down 24.2% on a year-over-year basis. During the same period last year, the company earned ($0.17) earnings per share. On average, equities analysts anticipate that Natera will post ($1.96) EPS for the current year.
TRADEMARK VIOLATION WARNING: This piece was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are viewing this piece on another publication, it was illegally stolen and reposted in violation of U.S. and international copyright & trademark legislation. The original version of this piece can be viewed at https://sportsperspectives.com/2017/05/19/natera-ntra-earns-media-impact-rating-of-0-26-updated-updated.html.
Natera Company Profile
Receive News & Ratings for Natera Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Natera Inc and related companies with MarketBeat.com's FREE daily email newsletter.